GlassScriptPhysician profile
Vernon A Orton
NPI 1083823009
$7,339.24
in general payments reported to CMS, 2019-2025
51 companies · $1,432 in 2025
The $1,432 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $942 · 2020: $231 · 2021: $345 · 2022: $1,902 · 2023: $1,287 · 2024: $1,200 · 2025: $1,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,918.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $742.70 | 2019-2025 | Provenge |
| Blue Earth Diagnostics | $665.15 | 2021-2025 | Posluma |
| Bayer Healthcare Pharmaceuticals INC. | $602.65 | 2019-2025 | |
| Astellas Pharma US INC | $530.76 | 2019-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $379.20 | 2019-2025 | |
| Janssen Biotech, INC. | $370.25 | 2019-2025 | Erleada, Akeega |
| Urogen Pharma, INC. | $325.03 | 2022-2025 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $319.36 | 2021-2025 | Pylarify |
| Novartis Pharmaceuticals Corporation | $255.27 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $238.77 | 2023-2025 | Gemtesa, Orgovyx |
| Accord Healthcare, INC. | $235.58 | 2022-2025 | |
| Medtronic USA, INC. | $198.90 | 2019-2020 | |
| Ethicon US, LLC | $195.24 | 2022-2023 | Echelon Flex, Stratafix |
| Endo Pharmaceuticals INC. | $193.36 | 2019-2024 | Xiaflex, Aveed, Edex |
| Endo USA, INC. | $182.86 | 2024-2025 | Xiaflex, Aveed |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $171.35 | 2022-2025 | Barrigel, Urolift |
| Boston Scientific Corporation | $153.16 | 2022-2025 | Rezum Generator |
| Antares Pharma, INC. | $134.76 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Abbvie INC. | $126.06 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $123.66 | 2019-2025 | Adstiladrin |
| Amgen INC. | $115.26 | 2019-2022 | |
| Karl Storz Endoscopy-America | $111.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $104.34 | 2021-2022 | |
| Myovant Sciences INC. | $80.06 | 2022 | |
| Urovant Sciences INC | $72.52 | 2021-2022 | |
| Coloplast Corp | $62.24 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $53.16 | 2025 | Keytruda, Welireg |
| Tempus Ai, INC | $52.06 | 2024-2025 | Xt Cdx |
| Ambu INC. | $48.83 | 2023-2024 | |
| Procept Biorobotics Corporation | $46.41 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Tolmar Pharmaceuticals, INC. | $45.93 | 2019-2020 | |
| Dentsply Ih INC. | $43.48 | 2020 | |
| Neotract INC. | $29.49 | 2020 | |
| Sun Pharmaceutical Industries INC. | $28.06 | 2023 | Yonsa |
| Zyla Life Sciences, INC. | $27.31 | 2019 | |
| Genzyme Corporation | $22.59 | 2019 | |
| Cycle Pharmaceuticals INC | $22.30 | 2024 | Tiopronin |
| Azurity Pharmaceuticals, INC. | $22.04 | 2025 | Azmiro |
| Halozyme INC | $20.09 | 2023 | |
| Travere Therapeutics, INC. | $19.98 | 2021-2022 | |
| Davol INC. | $19.51 | 2019 | |
| Cardinal Health 414 LLC | $18.89 | 2022 | |
| Telix Pharmaceuticals | $17.70 | 2022 | |
| Convatec INC. | $17.34 | 2019 | |
| Allergan, INC. | $15.05 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $14.96 | 2023 | Bard Urinary Drainage Bag |
| Janssen Scientific Affairs, LLC | $14.01 | 2019 | |
| Intuitive Surgical, INC. | $13.19 | 2019 | |
| Verity Pharmaceuticals INC. | $13.02 | 2023 | Trelstar |
| Axonics, INC. | $12.51 | 2022 | |
| Clarus Therapeutics INC. | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vernon Orton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.